Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists.
- Published In:
- International journal of physiology, pathophysiology and pharmacology, 4(2), 59-73 (2012)
- Authors:
- Land, Stephen C
- Database ID:
- RPEP-01990
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01990APA
Land, Stephen C. (2012). Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists.. International journal of physiology, pathophysiology and pharmacology, 4(2), 59-73.
MLA
Land, Stephen C. "Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists.." International journal of physiology, 2012.
RethinkPeptides
RethinkPeptides Research Database. "Inhibition of cellular and systemic inflammation cues in hum..." RPEP-01990. Retrieved from https://rethinkpeptides.com/research/land-2012-inhibition-of-cellular-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.